Famotidine – 5 g

Brand:
Cayman
CAS:
76824-35-6
Storage:
-20
UN-No:
Non-Hazardous - /

Famotidine is a histamine H2 receptor antagonist with a Ki value of 12 nM in fractionated guinea pig cerebral cortex membranes.{36463} It is selective for H2 over H1 and muscarinic receptors (Kis = 4 and 28 µM, respectively, in bovine cerebral cortex).{23214} Famotidine inhibits histamine-induced acid secretion in isolated canine parietal cells (IC50 = 0.6 µM).{17620} It also suppresses histamine-induced gastric acid secretion in dogs when administered orally and in anesthetized rats when administered intraduodenally (ID50s = 10 and 400 µg/kg, respectively).{17620} Formulations containing famotidine have been used in the treatment of ulcers, gastroesophageal reflux disease (GERD), and heartburn, as well as to decrease the risk of gastrointestinal toxicity associated with non-steroidal anti-inflammatory drugs (NSAIDs).  

 

Available on backorder

SKU: 23828 - 5 g Category:

Description

A histamine H2 receptor antagonist (Ki = 12 nM); selective for H2 over H1 and muscarinic receptors (Kis = 4 and 28 µM, respectively); inhibits histamine-stimulated acid secretion in isolated canine parietal cells (IC50 = 0.6 µM); suppresses histamine-induced gastric acid secretion in dogs when administered orally and in anesthetized rats when administered intraduodenally (ID50s = 10 and 400 µg/kg, respectively)


Formal name: 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)-propanimidamide

Synonyms:  MK-208|YM-11170

Molecular weight: 337.5

CAS: 76824-35-6

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Gastric Disease|Peptic Ulcers